Clinical Trials to Assess the Efficacy and Safety of HLIM

• Status: Unknown status
• Trial end date: 2019-10-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the efficacy and safety of HLIM

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: SamA Pharmaceutical Co., Ltd

Criteria

Inclusion Criteria:

• Age between 2 and 75

• Weight more than 11.5 kg

Exclusion Criteria:

• Has a history of hypersensitivity to IP ingredients

• Hypertension or Diabetes

• Smoking more than 20 pack-years